Bunazosin, a Selective α1 ‐Adrenoceptor Antagonist, as an Anti‐glaucoma Drug: Effects on Ocular Circulation and Retinal Neuronal Damage
- 1 March 2005
- journal article
- review article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 23 (1), 43-56
- https://doi.org/10.1111/j.1527-3466.2005.tb00156.x
Abstract
Bunazosin hydrochloride is a potent and selective alpha1-adrenoceptor antagonist that has been clinically used both as a systemic antihypertensive as well as an ocular hypotensive drug. In a number of studies, we have examined some effects of bunazosin hydrochloride that might indicate its potential as an anti-glaucoma drug. In normal rabbit eyes, topically instilled bunazosin hydrochloride reached the posterior retina by local penetration at concentrations sufficient to attenuate the phenylephrine- or endothelin-1 (ET-1)-induced constriction of retinal arteries. Furthermore, bunazosin hydrochloride improved the impairment of optic nerve head (ONH) blood flow, the prolongation of visual-evoked potentials (VEP) implicit time, the enlargement of the optic disk cup, and the decrease in the number of retinal ganglion cell layer cells induced by repeated injections of ET-1 in rabbits. Topically instilled bunazosin hydrochloride improved the reductions in ONH capillary blood flow and VEP amplitude induced in rabbit eyes by nitric oxide synthase inhibition. In rat primary retinal cultures, bunazosin hydrochloride reduced glutamate-induced neuronal cell death, presumably through a Na+ channel blocking effect. In healthy humans, topically instilled bunazosin hydrochloride reportedly increases blood velocity in the ONH, retina and choroid, without significantly altering either blood pressure or heart rate. These results indicate that bunazosin hydrochloride exerts both an improvement effect within the ocular circulation and a direct neuroprotective effect. Hence, bunazosin hydrochloride may be useful as a therapeutic drug against ischemic retinal diseases (such as glaucoma and retinal vascular occlusive diseases) that are associated with disturbances of the ocular circulation.Keywords
This publication has 25 references indexed in Scilit:
- Amelioration of Endothelin-1–Induced Optic Nerve Head Ischemia by Topical BunazosinCurrent Eye Research, 2005
- Effects of Topically Instilled Bunazosin, an α1-Adrenoceptor Antagonist, on Constrictions Induced by Phenylephrine and ET-1 in Rabbit Retinal ArteriesPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2004
- Effects of Topically Instilled Bunazosin Hydrochloride and Other Ocular Hypotensive Drugs on Endothelin-1-induced Constriction in Rabbit Retinal ArteriesJapanese Journal of Ophthalmology, 2004
- Bunazosin hydrochloride reduces glutamate-induced neurotoxicity in rat primary retinal culturesBrain Research, 2004
- Amelioration by Topical Bunazosin Hydrochloride of the Impairment in Ocular Blood Flow Caused by Nitric Oxide Synthase Inhibition in RabbitsJournal of Ocular Pharmacology and Therapeutics, 2003
- Endothelin: Is It a Contributor to Glaucoma Pathophysiology?Journal of Glaucoma, 2002
- A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patientsOphthalmology, 2000
- Excitotoxic damage of retinal glial cells depends upon normal neuron-glial interactionsGlia, 1998
- Comparison of pre- and postsynaptic .ALPHA.-adrenoceptor blocking effects of E-643 in the isolated vas deferens of the rat.The Japanese Journal of Pharmacology, 1981